Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-07
2006-03-07
Fay, Zohreh (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S588000, C514S912000
Reexamination Certificate
active
07008960
ABSTRACT:
Methods and preparatons for treating disorders of the eye and/or causing posterior vitreous disconnection or disinsertion. Preparations containing a) urea, b) urea derivatives (e.g., hydroxyurea, thiourea), c) a non-steroidal anti-inflamatory agents, d) antmetabolites, e) urea, urea derivatives, non-enzymatic proteins, nucleosides, nucleotides and their derivatives (e.g., adenine, adenosine, cytosine, cytadine, guanine, guanitadine, guanidinium, thymidine, thimitadine, uradine, uracil, cystine), uric acid, calcium acetal salicylate, ammonium sulfate or other compound capable of causing non-enzymatic dissolution of the hyaloid membrane or e) any of the possible combinations thereof, are administered to the eye in therapeutically effective amounts.
REFERENCES:
patent: 5110493 (1992-05-01), Cherng-Chyi et al.
patent: 5292509 (1994-03-01), Hageman
patent: 5441984 (1995-08-01), Heath, Jr. et al.
patent: 5470881 (1995-11-01), Charlton et al.
patent: 5554187 (1996-09-01), Rizzo, III
patent: 5629344 (1997-05-01), Charlton et al.
patent: 5866120 (1999-02-01), Karageozian et al.
patent: 5891084 (1999-04-01), Lee
patent: 5891913 (1999-04-01), Sallmann et al.
patent: 6039943 (2000-03-01), Karageozian et al.
patent: 6242468 (2001-06-01), Li et al.
patent: 6335348 (2002-01-01), Ross et al.
patent: 6384056 (2002-05-01), Ross et al.
patent: 6395758 (2002-05-01), Ross et al.
patent: 6399648 (2002-06-01), Ross et al.
patent: 6506788 (2003-01-01), Ross et al.
patent: 6551590 (2003-04-01), Karageozian et al.
Buyan Robert D.
Fay Zohreh
Stout, Uxa Buyan & Mullins, LLP
Vitreo-Retinal Technologies, Inc.
LandOfFree
Agents for intravitreal administration to treat or prevent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agents for intravitreal administration to treat or prevent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for intravitreal administration to treat or prevent... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3564761